135 related articles for article (PubMed ID: 10972178)
21. Vasoactive intestinal peptide (VIP) inhibits human renal cell carcinoma proliferation.
Vacas E; Fernández-Martínez AB; Bajo AM; Sánchez-Chapado M; Schally AV; Prieto JC; Carmena MJ
Biochim Biophys Acta; 2012 Oct; 1823(10):1676-85. PubMed ID: 22728770
[TBL] [Abstract][Full Text] [Related]
22. Murine mucosal T cells have VIP receptors functionally distinct from those on intestinal epithelial cells.
Blum AM; Mathew R; Cook GA; Metwali A; Felman R; Weinstock JV
J Neuroimmunol; 1992 Jul; 39(1-2):101-8. PubMed ID: 1320055
[TBL] [Abstract][Full Text] [Related]
23. A human melanoma-derived cell line (IGR39) with a very high number of vasoactive-intestinal-peptide (VIP) receptors. 2. Effect of VIP on cAMP production and on cell-surface VIP-binding sites.
Martin JM; Luis J; Marvaldi J; Pichon J; Pic P
Eur J Biochem; 1989 Mar; 180(2):435-9. PubMed ID: 2538331
[TBL] [Abstract][Full Text] [Related]
24. Synergistic action of cyclic adenosine monophosphate- and calcium-mediated chloride secretion in a colonic epithelial cell line.
Cartwright CA; McRoberts JA; Mandel KG; Dharmsathaphorn K
J Clin Invest; 1985 Nov; 76(5):1837-42. PubMed ID: 2997291
[TBL] [Abstract][Full Text] [Related]
25. Vasoactive intestinal peptide receptor activity and specificity during enterocyte-like differentiation and retrodifferentiation of the human colonic cancerous subclone HT29-18.
Chastre E; Emami S; Rosselin G; Gespach C
FEBS Lett; 1985 Sep; 188(2):197-204. PubMed ID: 2993022
[TBL] [Abstract][Full Text] [Related]
26. Vasoactive intestinal peptide receptor regulation and reversible desensitization in human colonic carcinoma cells in culture.
Boissard C; Marie JC; Hejblum G; Gespach C; Rosselin G
Cancer Res; 1986 Sep; 46(9):4406-13. PubMed ID: 3015387
[TBL] [Abstract][Full Text] [Related]
27. Cyclic adenosine-3',5'-monophosphate production is greater in rabbit duodenal crypt than in villus cells.
Amelsberg M; Amelsberg A; Ainsworth MA; Hogan DL; Isenberg JI
Scand J Gastroenterol; 1996 Mar; 31(3):233-9. PubMed ID: 8833352
[TBL] [Abstract][Full Text] [Related]
28. See-saw signal processing: reciprocal effects of stimulus deprivation on vasoactive intestinal peptide-stimulated adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate accumulation in rat pinealocytes.
Chik CL; Ho AK
Endocrinology; 1991 Feb; 128(2):850-6. PubMed ID: 1846590
[TBL] [Abstract][Full Text] [Related]
29. cAMP immunocytochemistry provides evidence for functional VIP receptors in trachea.
Lazarus SC; Basbaum CB; Barnes PJ; Gold WM
Am J Physiol; 1986 Jul; 251(1 Pt 1):C115-9. PubMed ID: 2425626
[TBL] [Abstract][Full Text] [Related]
30. Regulation by vasoactive intestinal peptide, histamine, somatostatin-14 and -28 of cyclic adenosine monophosphate levels in gastric glands isolated from the guinea pig fundus or antrum.
Gespach C; Hui Bon Hoa D; Rosselin G
Endocrinology; 1983 May; 112(5):1597-606. PubMed ID: 6131813
[TBL] [Abstract][Full Text] [Related]
31. VIP interaction with intestinal epithelial cells and liver plasma membranes from hepatectomized rats.
Prieto JC; Diaz-Juarez JL; Arilla E
Peptides; 1986; 7 Suppl 1():273-8. PubMed ID: 3018701
[TBL] [Abstract][Full Text] [Related]
32. Impact of VIP and cAMP on the regulation of TNF-alpha and IL-10 production: implications for rheumatoid arthritis.
Foey AD; Field S; Ahmed S; Jain A; Feldmann M; Brennan FM; Williams R
Arthritis Res Ther; 2003; 5(6):R317-28. PubMed ID: 14680506
[TBL] [Abstract][Full Text] [Related]
33. Ontogenic development of vasoactive intestinal peptide receptors in rat intestinal cells and liver.
Chastre E; Emami S; Rosselin G; Gespach C
Endocrinology; 1987 Dec; 121(6):2211-21. PubMed ID: 2824182
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of VIP-stimulated intestinal secretion and cyclic AMP production by somatostatin in the rat.
Carter RF; Bitar KN; Zfass AM; Makhlouf GM
Gastroenterology; 1978 Apr; 74(4):726-30. PubMed ID: 204536
[TBL] [Abstract][Full Text] [Related]
35. Vasoactive intestinal peptide prevents PKCε-induced intestinal epithelial barrier disruption during EPEC infection.
Morampudi V; Conlin VS; Dalwadi U; Wu X; Marshall KC; Nguyen C; Vallance BA; Jacobson K
Am J Physiol Gastrointest Liver Physiol; 2015 Mar; 308(5):G389-402. PubMed ID: 25501546
[TBL] [Abstract][Full Text] [Related]
36. Involvement of cyclic AMP - PKA pathway in VIP-induced, charybdotoxin-sensitive relaxation of longitudinal muscle of the distal colon of Wistar-ST rats.
Kishi M; Takeuchi T; Katayama H; Yamazaki Y; Nishio H; Hata F; Takewaki T
Br J Pharmacol; 2000 Jan; 129(1):140-6. PubMed ID: 10694213
[TBL] [Abstract][Full Text] [Related]
37. Vasoactive intestinal peptide (VIP) stimulates rat prostatic epithelial cell proliferation.
Juarranz MG; Bodega G; Prieto JC; Guijarro LG
Prostate; 2001 Jun; 47(4):285-92. PubMed ID: 11398176
[TBL] [Abstract][Full Text] [Related]
38. Vasoactive intestinal peptide inhibits cytokine production in T lymphocytes through cAMP-dependent and cAMP-independent mechanisms.
Wang HY; Jiang X; Gozes I; Fridkin M; Brenneman DE; Ganea D
Regul Pept; 1999 Oct; 84(1-3):55-67. PubMed ID: 10535409
[TBL] [Abstract][Full Text] [Related]
39. Alpha 1-adrenergic potentiation of vasoactive intestinal peptide stimulation of rat pinealocyte adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate: evidence for a role of calcium and protein kinase-C.
Chik CL; Ho AK; Klein DC
Endocrinology; 1988 Feb; 122(2):702-8. PubMed ID: 2892667
[TBL] [Abstract][Full Text] [Related]
40. Effects of vasoactive intestinal peptide and pancreatic polypeptide in rabbit intestine.
Camilleri M; Cooper BT; Adrian TE; Bloom SR; Chadwick VS
Gut; 1981 Jan; 22(1):14-8. PubMed ID: 6257593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
